| |||
 | |||
 |
Calcium | ||
|
Magnesium | ||
|
Vitamin D | ||
|
Vitamin E | ||
|
Zinc | ||
|
| |||
| U.S. Brand Names |
| Andro/Fem® Injection; Deladumone® Injection; depAndrogyn® Injection; Depo-Testadiol® Injection; Depotestogen® Injection; Duo-Cyp® Injection; Duratestrin® Injection; Valertest No.1® Injection |
 |
| Generic Available |
|
No |
|
| Synonyms |
| Estradiol Cypionate and Testosterone Cypionate; Estradiol Valerate and Testosterone Enanthate; Testosterone and Estradiol |
|
| Pharmacological Index |
|
Estrogen Derivative |
|
| Use |
|
Vasomotor symptoms associated with menopause; postpartum breast engorgement |
|
| Pregnancy Risk Factor |
|
X |
|
| Contraindications |
|
Thromboembolic disorders; active arterial thrombosis; thyroid dysfunction; blood dyscrasias; hypersensitivity to estradiol or testosterone |
|
| Adverse Reactions |
|
1% to 10%: Central nervous system: Stroke, depression, dizziness, anxiety, headache, migraine Dermatologic: Chloasma, melasma, rash Endocrine & metabolic: Alterations in frequency and flow of menses, breast tenderness or enlargement, decreased glucose tolerance, increased triglycerides and LDL Gastrointestinal: Nausea, GI distress Hepatic: Cholestatic jaundice Miscellaneous: Increased susceptibility to Candida infection |
|
| Usual Dosage |
|
Adults: All dosage needs to be adjusted based upon the patient's response |
|
| Administration |
|
For intramuscular use only |
|
| Mental Health: Effects on Mental Status |
|
May cause anxiety or depression |
|
| Mental Health: Effects on Psychiatric Treatment |
|
None reported |
|
| Dental Health: Local Anesthetic/Vasoconstrictor Precautions |
|
No information available to require special precautions |
|
| Dental Health: Effects on Dental Treatment |
|
No effects or complications reported |
|
| Dosage Forms |
|
Injection: Androgyn L.A.®, Deladumone®, Estra-Testrin®, Valertest No.1®: Estradiol valerate 4 mg and testosterone enanthate 90 mg per mL in sesame oil (5 mL, 10 mL) |
|
|
Copyright © 2007 Drugs Area |
